: Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism 2000, 49:1118–1123.PubMedCrossRef 9. Tatar M, Bartke A, Antebi A: The endocrine regulation of aging by insulin-like signals. Science 2003, 299:1346–1351.PubMedCrossRef Fulvestrant clinical trial 10. Liu H, Fergusson MM, Castilho

RM, Liu J, Cao L, Chen J, Malide D, Rovira II, Schimel D, Kuo CJ, et al.: Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007, 317:803–806.PubMedCrossRef 11. Liu S, Gupta A, Quarles LD: Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 2007, 16:329–335.PubMedCrossRef 12. Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, Amaki T, Mori I, Nakamura Y, Sato M, et al.: In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 2002, 39:838–843.PubMedCrossRef 13. Saito Y, Nakamura T, Ohyama Y, Suzuki T, Iida A, Shiraki-Iida T, Kuro-o M, Nabeshima Y, Kurabayashi

M, Nagai R: In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 2000, 276:767–772.PubMedCrossRef 14. Hofmann F, García-Echeverría C: Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today 2005, 10:1041–1047.PubMedCrossRef 15. Tao Phospholipase D1 Y, Pinzi V, Bourhis J, Deutsch E: Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway-therapeutic perspectives selleck in cancer. Nat Clin Pract Oncol 2007, 4:591–602.PubMedCrossRef 16. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X:

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 1999, 91:151–156.PubMedCrossRef 17. Mattarocci S, Abbruzzese C, Mileo AM, Visca P, Antoniani B, Alessandrini G, Facciolo F, Felsani A, Radulescu RT, Paggi MG: Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer. J Cell Physiol 2009, 221:766–770.PubMedCrossRef 18. Ma Z, Dong A, Kong M, Qian J: Silencing of the type 1 insulin-like growth factor receptor increases the sensitivity to apoptosis and inhibits invasion in human lung adenocarcinoma A549 cells. Cell Mol Biol Lett 2007, 12:556–572.PubMedCrossRef 19. Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP, Rubinek T: Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 2008, 27:7094–7105.PubMedCrossRef 20. Dong AQ, Kong MJ, Ma ZY, Qian JF, Xu XH: Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int 2007, 31:500–507.PubMedCrossRef 21.